Remission criteria in schizophrenia;Remissiecriteria voor de diagnose schizofrenie

Tijdschrift voor Psychiatrie

Volumn 49, Issue 1, 2007, Pages 21-26

  Van Os, J ^a,c   Kahn, R ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Remission; Schizophrenia; Standards; Validation

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; DISEASE COURSE; HUMAN; INCIDENCE; OUTCOME ASSESSMENT; PLASTICITY; REMISSION; REVIEW; SCHIZOPHRENIA; TREATMENT OUTCOME; VALIDATION STUDY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); REMISSION INDUCTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 33846514778     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Andreasen, N.C., Carpenter, W.T. Jr., Kane, J.M., e.a. (2005). Remission in schizophrenia: proposed criteria and rationale for consensus. The American Journal of Psychiatry, 162, 441-449.
2. Bakker, S.C., Hoogendoorn, M.L., Selten, J.P., e.a. (2004). Neuregulin i: genetic support for schizophrenia subtypes. Molecular Psychiatry, 9, 1061-1063.
3. Boydell, J., van Os, J., McKenzie, K., e.a. (2001). Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. British Medical Journal, 323, 1336-1338.
4. Fleischhacker, W. W., Keet, I.P., & Kahn, R.S. (2005). The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial. Schizophrenia Research, 78, 147-156.
5. Frank, E., Prien, R.F., Jarrett, R.B., e.a. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry, 48, 851-855.
6. Kane, J.M., Leucht, S., Carpenter, D., e.a. (2003). Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. The Journal of Clinical Psychiatry, 64(Suppl. 12), 5-19.
7. Lasser, R.A., Bossie, C.A., Gharabawi, G.M., e.a. (2005). Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection. Schizophrenia Research, 77, 215-227.
8. Lieberman, J.A., Tollefson, G.D., Charles, C., e.a. (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry, 62, 361-370.
9. Os, J. van, Burns, T., Cavallaro, R., e.a. (2006a). Standardized remission criteria in schizophrenia. Acta Psychiatrica Scandinavica, 113, 91-95.
10. Os, J. van, & Delespaul, P. (2005). Toward a world consensus on prevention of schizophrenia. Dialogues in Clinical Neuroscience, 7, 53-67.
11. Os, J. van, Drukker, M., á Campo, J., e.a. (2006b). Validation of remission criteria for schizophrenia. The American Journal of Psychiatry, 163, 2000-2002.
12. Os, J. van, Krabbendam, L., Myin-Germeys, I., e.a. (2005). The schizophrenia envirome. Current Opinion in Psychiatry, 18, 141-145.
13. Rijsdijk, F.V., van Haren, N.E., Picchioni, M.M., e.a. (2005). Brain MRI abnormalities in schizophrenia: same genes or same environment? Psychological Medicine, 35, 1399-1409.
14. Sawa, A., & Snyder, S.H. (2002). Schizophrenia: diverse approaches to a complex disease. Science, 296, 692-695.
15. Tenback, D.E., van Harten, P.N., Slooff, C.J., e.a. (2005). Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study. The Journal of Clinical Psychiatry, 1130-1133.